Abbott Next Generation Drug Eluting Stent 48mm Study
Public ClinicalTrials.gov record NCT04282148. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Clinical Investigation to Assess the Abbott Next Generation Drug Eluting Stent 48mm Everolimus Eluting Coronary Stent System (EECSS) in Treatment of de Novo Native Coronary Artery Disease
Study identification
- NCT ID
- NCT04282148
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Abbott Medical Devices
- Industry
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- ABT NG DES 48 EECSS Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 16, 2020
- Primary completion
- Oct 4, 2022
- Completion
- Sep 16, 2023
- Last update posted
- Jan 7, 2025
2020 – 2023
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HonorHealth | Scottsdale | Arizona | 85258 | — |
| Scripps Memorial Hospital - La Jolla | La Jolla | California | 92037 | — |
| UCLA Medical Center Santa Monica | Santa Monica | California | 90404 | — |
| The Cardiac & Vascular Institute Research Foundation, LLC | Gainesville | Florida | 32605 | — |
| Shands at the University of Florida | Gainesville | Florida | 32610 | — |
| Via Christi Regional Medical Center - St. Francis Campus | Wichita | Kansas | 67214 | — |
| Cardiovascular Research Institute of Kansas | Wichita | Kansas | 67226 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Minneapolis Heart Institute | Minneapolis | Minnesota | 55407 | — |
| North Mississippi Medical Center | Tupelo | Mississippi | 38801 | — |
| St. Patrick Hospital | Missoula | Montana | 59802 | — |
| Mount Sinai Hospital | New York | New York | 10019 | — |
| The Lindner Center | Cincinnati | Ohio | 45219 | — |
| St. Vincent Mercy Medical Center | Toledo | Ohio | 43608 | — |
| Pinnacle Health System | Harrisburg | Pennsylvania | 17105 | — |
| Greenville Health System | Greenville | South Carolina | 29605 | — |
| Baylor Scott & White Heart & Vascular Hospital | Dallas | Texas | 75226 | — |
| The Heart Hospital Baylor Plano | Plano | Texas | 75093 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04282148, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2025 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04282148 live on ClinicalTrials.gov.